Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$12.38 - $13.69 $40,321 - $44,588
-3,257 Reduced 6.12%
49,963 $623,000
Q2 2023

Aug 14, 2023

SELL
$13.13 - $14.17 $40,663 - $43,884
-3,097 Reduced 5.5%
53,220 $720,000
Q1 2023

May 15, 2023

BUY
$13.37 - $14.94 $111,799 - $124,928
8,362 Added 17.44%
56,317 $784,000
Q4 2022

Feb 14, 2023

BUY
$13.55 - $15.23 $649,790 - $730,354
47,955 New
47,955 $681,000
Q3 2020

Nov 16, 2020

SELL
$16.71 - $19.06 $228,993 - $261,198
-13,704 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$14.22 - $18.38 $263,041 - $339,993
-18,498 Reduced 57.44%
13,704 $246,000
Q1 2020

May 15, 2020

BUY
$12.22 - $17.99 $92,872 - $136,724
7,600 Added 30.89%
32,202 $483,000
Q4 2019

Feb 14, 2020

BUY
$14.63 - $17.84 $359,927 - $438,899
24,602 New
24,602 $429,000

Others Institutions Holding HQL

About TEKLA LIFE SCIENCES INVESTORS


  • Ticker HQL
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...
More about HQL
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.